ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Prime Medicine Inc

Prime Medicine Inc (PRME)

3,20
0,23
(7,74%)
Geschlossen 23 November 10:00PM
3,26
0,06
(1,88%)
Nach Börsenschluss: 12:53AM

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Current Price
3,26
Gebot
3,05
Fragen
3,35
Volumen
1.486.969
2,96 Tagesbereich 3,29
2,85 52-Wochen-Bereich 9,86
Marktkapitalisierung
Handelsende
2,97
Handelsbeginn
2,96
Letzter Handelszeitpunkt
Finanzvolumen
US$ 4.711.111
VWAP
3,1683
Durchschnittliches Volumen (3 Mio.)
1.571.776
Ausgegebene Aktien
131.160.842
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-2,12
Gewinn pro Aktie (EPS)
-1,51
Erlöse
-
Nettogewinn
-198,13M

Über Prime Medicine Inc

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome a... Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs. Mehr anzeigen

Sektor
Biological Pds,ex Diagnstics
Branche
Biological Pds,ex Diagnstics
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Prime Medicine Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker PRME. The last closing price for Prime Medicine was US$2,97. Over the last year, Prime Medicine shares have traded in a share price range of US$ 2,85 to US$ 9,86.

Prime Medicine currently has 131.160.842 shares in issue. The market capitalisation of Prime Medicine is US$389,55 million. Prime Medicine has a price to earnings ratio (PE ratio) of -2.12.

PRME Neueste Nachrichten

Prime Medicine Reports Third Quarter 2024 Financial Results and Provides Business Updates

-- Presented initial in vivo data for universal liver-targeted LNP and Wilson’s Disease program at ESGCT; initiated IND-enabling activities for Wilson’s Disease program in 4Q 2024 and remains on...

Prime Medicine to Participate in Upcoming Investor Conferences

CAMBRIDGE, Mass., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic...

Prime Medicine Presents In Vivo Proof-of-Concept Data Highlighting Interim Preclinical Advances in its Wilson’s Disease Program and the Broad Potential of its Universal Liver-Targeted LNP at ESGCT 31st Annual Congress

Delivery of Prime Editors with a proprietary, universal liver-targeted LNP was well tolerated, with no safety concerns or detectable off-target edits observed across multiple preclinical studies...

Prime Medicine to Highlight New Preclinical Data, Including In Vivo Data in Wilson’s Disease, at Upcoming Scientific Meetings

-- On-track to initiate IND-enabling activities for Wilson’s Disease program in 4Q 2024, with IND or CTA filing expected in 1H 2026 -- CAMBRIDGE, Mass., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Prime...

Prime Medicine Unveils Strategically Focused Pipeline

-- Prioritizing Set of High Value Programs in Core Areas of Focus; Modularity of Prime Editing Platform Expected to Allow Prime Medicine to Generate Follow-on Candidates Rapidly and Efficiently...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.35-9.695290858733.613.612.8513016413.14937114CS
4-0.92-22.0095693784.184.712.8510474323.79840386CS
12-1.06-24.5370370374.325.022.8515717763.81268063CS
26-4.82-59.65346534658.088.14422.8511546214.54998655CS
52-3.67-52.95815295826.939.862.859209975.46512596CS
156-15.71-82.814971006918.9721.73012.856197817.67832095CS
260-15.71-82.814971006918.9721.73012.856197817.67832095CS
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
PDYNPalladyne AI Corporation
US$ 4,59
(129,50%)
83,07M
QMCOQuantum Corporation
US$ 9,11
(126,62%)
39,48M
NANano Labs Ltd
US$ 8,26
(89,02%)
2,03M
XCURExicure Inc
US$ 18,60
(71,27%)
4,59M
SKKSKK Holdings Limited
US$ 1,75
(59,09%)
107,47M
AMIXAutonomix Medical Inc
US$ 6,21
(-54,07%)
946,09k
CETXCemtrex Inc
US$ 0,1146
(-41,74%)
24,39M
MSWMing Shing Group Holdings Ltd
 5,90
(-35,52%)
417,08k
RMSGReal Messenger Corporation
US$ 3,09
(-26,25%)
313,51k
ENSCEnsysce Biosciences Inc
US$ 0,4414
(-25,49%)
4M
ELABElevai Labs Inc
US$ 0,0201
(-0,50%)
415,87M
NVDANVIDIA Corporation
US$ 141,95
(-3,22%)
229,93M
SMCISuper Micro Computer Inc
US$ 33,15
(11,62%)
155,43M
VRPXVirpax Pharmaceuticals Inc
US$ 0,5501
(-6,72%)
154,17M
SOUNSoundHound AI Inc
US$ 8,24
(18,05%)
103,6M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht